Annual gross profit:
$8.06B+$419.00M(+5.48%)Summary
- As of today (April 17, 2025), TEVA annual gross profit is $8.06 billion, with the most recent change of +$419.00 million (+5.48%) on December 31, 2024.
- During the last 3 years, TEVA annual gross profit has risen by +$470.00 million (+6.19%).
- TEVA annual gross profit is now -30.80% below its all-time high of $11.65 billion, reached on December 31, 2016.
Performance
TEVA Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$2.12B-$27.00M(-1.26%)Summary
- As of today (April 17, 2025), TEVA quarterly gross profit is $2.12 billion, with the most recent change of -$27.00 million (-1.26%) on December 31, 2024.
- Over the past year, TEVA quarterly gross profit has increased by +$350.00 million (+19.76%).
- TEVA quarterly gross profit is now -33.39% below its all-time high of $3.18 billion, reached on December 31, 2016.
Performance
TEVA quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$8.06B-$294.00M(-3.52%)Summary
- As of today (April 17, 2025), TEVA TTM gross profit is $8.06 billion, with the most recent change of -$294.00 million (-3.52%) on December 31, 2024.
- Over the past year, TEVA TTM gross profit has increased by +$231.00 million (+2.95%).
- TEVA TTM gross profit is now -31.08% below its all-time high of $11.70 billion, reached on March 31, 2017.
Performance
TEVA TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
TEVA Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.5% | +19.8% | +3.0% |
| 3 y3 years | +6.2% | +18.2% | +9.3% |
| 5 y5 years | +7.0% | +3.6% | +4.4% |
TEVA Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +15.7% | -12.2% | +34.1% | -3.5% | +18.3% |
| 5 y | 5-year | at high | +15.7% | -12.2% | +34.1% | -3.5% | +18.3% |
| alltime | all time | -30.8% | >+9999.0% | -33.4% | +2291.2% | -31.1% | +8120.2% |
Teva Pharmaceutical Industries Limited Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $8.06B(+5.5%) | $2.12B(-1.3%) | $8.06B(-3.5%) |
| Sep 2024 | - | $2.15B(+6.1%) | $8.36B(+3.7%) |
| Jun 2024 | - | $2.02B(+14.3%) | $8.06B(+2.9%) |
| Mar 2024 | - | $1.77B(-26.7%) | $7.83B(+2.5%) |
| Dec 2023 | $7.64B(+9.6%) | $2.42B(+30.5%) | $7.64B(+9.2%) |
| Sep 2023 | - | $1.85B(+3.1%) | $7.00B(+2.7%) |
| Jun 2023 | - | $1.80B(+13.5%) | $6.82B(+0.0%) |
| Mar 2023 | - | $1.58B(-10.6%) | $6.82B(-2.3%) |
| Dec 2022 | $6.97B(-8.2%) | $1.77B(+6.1%) | $6.97B(-3.9%) |
| Sep 2022 | - | $1.67B(-7.0%) | $7.25B(-1.7%) |
| Jun 2022 | - | $1.79B(+3.1%) | $7.38B(-1.1%) |
| Mar 2022 | - | $1.74B(-15.1%) | $7.46B(-1.8%) |
| Dec 2021 | $7.59B(-1.7%) | $2.05B(+14.3%) | $7.59B(+0.0%) |
| Sep 2021 | - | $1.79B(-4.2%) | $7.59B(-0.8%) |
| Jun 2021 | - | $1.87B(-0.3%) | $7.65B(+1.5%) |
| Mar 2021 | - | $1.88B(-8.3%) | $7.54B(-2.4%) |
| Dec 2020 | $7.73B(+2.5%) | $2.05B(+10.6%) | $7.73B(+1.2%) |
| Sep 2020 | - | $1.85B(+5.0%) | $7.64B(+0.3%) |
| Jun 2020 | - | $1.76B(-14.5%) | $7.61B(-1.7%) |
| Mar 2020 | - | $2.06B(+5.4%) | $7.74B(+2.7%) |
| Dec 2019 | $7.54B(-9.1%) | $1.96B(+7.0%) | $7.54B(-0.2%) |
| Sep 2019 | - | $1.83B(-3.3%) | $7.55B(-1.9%) |
| Jun 2019 | - | $1.89B(+2.0%) | $7.70B(-1.8%) |
| Mar 2019 | - | $1.86B(-5.8%) | $7.84B(-5.5%) |
| Dec 2018 | $8.30B(-21.8%) | $1.97B(-0.3%) | $8.30B(-3.5%) |
| Sep 2018 | - | $1.98B(-2.8%) | $8.60B(-7.3%) |
| Jun 2018 | - | $2.03B(-12.2%) | $9.27B(-8.1%) |
| Mar 2018 | - | $2.31B(+1.9%) | $10.09B(-4.9%) |
| Dec 2017 | $10.62B(-8.9%) | $2.27B(-14.3%) | $10.62B(-7.9%) |
| Sep 2017 | - | $2.65B(-7.2%) | $11.53B(-1.3%) |
| Jun 2017 | - | $2.85B(+0.6%) | $11.68B(-0.2%) |
| Mar 2017 | - | $2.84B(-10.8%) | $11.70B(+0.4%) |
| Dec 2016 | $11.65B(+2.6%) | $3.18B(+13.7%) | $11.65B(+3.0%) |
| Sep 2016 | - | $2.80B(-2.6%) | $11.32B(+0.3%) |
| Jun 2016 | - | $2.88B(+3.1%) | $11.29B(-0.2%) |
| Mar 2016 | - | $2.79B(-2.0%) | $11.31B(-0.4%) |
| Dec 2015 | $11.36B(+2.7%) | $2.85B(+2.7%) | $11.36B(-0.4%) |
| Sep 2015 | - | $2.77B(-4.5%) | $11.40B(-0.3%) |
| Jun 2015 | - | $2.90B(+2.3%) | $11.44B(+2.2%) |
| Mar 2015 | - | $2.84B(-1.8%) | $11.20B(+1.3%) |
| Dec 2014 | $11.06B(+3.3%) | $2.89B(+2.8%) | $11.06B(-0.0%) |
| Sep 2014 | - | $2.81B(+5.6%) | $11.06B(+1.6%) |
| Jun 2014 | - | $2.66B(-1.3%) | $10.88B(+0.6%) |
| Mar 2014 | - | $2.70B(-6.8%) | $10.81B(+1.0%) |
| Dec 2013 | $10.71B(+0.5%) | $2.89B(+10.0%) | $10.71B(+1.0%) |
| Sep 2013 | - | $2.63B(+1.4%) | $10.60B(+0.3%) |
| Jun 2013 | - | $2.59B(+0.1%) | $10.57B(-0.6%) |
| Mar 2013 | - | $2.59B(-7.0%) | $10.63B(-0.2%) |
| Dec 2012 | $10.65B(+11.9%) | $2.79B(+7.1%) | $10.65B(-0.9%) |
| Sep 2012 | - | $2.60B(-2.1%) | $10.75B(+3.4%) |
| Jun 2012 | - | $2.66B(+1.8%) | $10.39B(+4.6%) |
| Mar 2012 | - | $2.61B(-9.4%) | $9.94B(+4.4%) |
| Dec 2011 | $9.52B(+5.0%) | $2.88B(+28.3%) | $9.52B(+4.6%) |
| Sep 2011 | - | $2.25B(+2.1%) | $9.10B(-2.4%) |
| Jun 2011 | - | $2.20B(+0.5%) | $9.32B(+0.9%) |
| Mar 2011 | - | $2.19B(-11.2%) | $9.24B(+1.9%) |
| Dec 2010 | $9.06B(+23.0%) | $2.46B(-0.1%) | $9.06B(+4.2%) |
| Sep 2010 | - | $2.47B(+16.3%) | $8.70B(+6.6%) |
| Jun 2010 | - | $2.12B(+5.4%) | $8.16B(+4.5%) |
| Mar 2010 | - | $2.01B(-4.1%) | $7.81B(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $7.37B(+23.4%) | $2.10B(+8.9%) | $7.37B(+7.3%) |
| Sep 2009 | - | $1.93B(+9.0%) | $6.87B(+6.8%) |
| Jun 2009 | - | $1.77B(+12.6%) | $6.43B(+4.3%) |
| Mar 2009 | - | $1.57B(-1.8%) | $6.17B(+3.3%) |
| Dec 2008 | $5.97B(+22.4%) | $1.60B(+7.2%) | $5.97B(+4.4%) |
| Sep 2008 | - | $1.49B(-0.9%) | $5.72B(+4.4%) |
| Jun 2008 | - | $1.50B(+9.7%) | $5.47B(+5.0%) |
| Mar 2008 | - | $1.37B(+1.9%) | $5.21B(+6.9%) |
| Dec 2007 | $4.88B(+14.5%) | $1.35B(+7.8%) | $4.88B(+5.3%) |
| Sep 2007 | - | $1.25B(+0.6%) | $4.63B(-0.3%) |
| Jun 2007 | - | $1.24B(+19.9%) | $4.64B(+1.6%) |
| Mar 2007 | - | $1.04B(-5.9%) | $4.57B(+7.3%) |
| Dec 2006 | $4.26B(+71.7%) | $1.10B(-12.6%) | $4.26B(+11.1%) |
| Sep 2006 | - | $1.26B(+7.7%) | $3.83B(+20.2%) |
| Jun 2006 | - | $1.17B(+61.8%) | $3.19B(+22.7%) |
| Mar 2006 | - | $724.00M(+7.1%) | $2.60B(+4.9%) |
| Dec 2005 | $2.48B(+10.8%) | $675.90M(+9.3%) | $2.48B(+2.5%) |
| Sep 2005 | - | $618.60M(+6.3%) | $2.42B(+1.2%) |
| Jun 2005 | - | $581.80M(-3.6%) | $2.39B(+1.2%) |
| Mar 2005 | - | $603.70M(-1.9%) | $2.36B(+5.5%) |
| Dec 2004 | $2.24B(+47.4%) | $615.70M(+4.4%) | $2.24B(+8.9%) |
| Sep 2004 | - | $589.60M(+6.6%) | $2.06B(+11.5%) |
| Jun 2004 | - | $553.30M(+15.2%) | $1.84B(+11.7%) |
| Mar 2004 | - | $480.40M(+10.9%) | $1.65B(+8.7%) |
| Dec 2003 | $1.52B(+38.7%) | $433.00M(+14.8%) | $1.52B(+6.6%) |
| Sep 2003 | - | $377.20M(+4.7%) | $1.43B(+8.1%) |
| Jun 2003 | - | $360.30M(+3.4%) | $1.32B(+9.4%) |
| Mar 2003 | - | $348.40M(+2.7%) | $1.21B(+10.0%) |
| Dec 2002 | $1.10B(+29.3%) | $339.20M(+25.4%) | $1.10B(+10.0%) |
| Sep 2002 | - | $270.60M(+9.5%) | $996.09M(+7.0%) |
| Jun 2002 | - | $247.10M(+3.6%) | $931.19M(+4.8%) |
| Mar 2002 | - | $238.50M(-0.6%) | $888.84M(+4.9%) |
| Dec 2001 | $847.29M(+7.7%) | $239.89M(+16.6%) | $847.30M(-6.7%) |
| Sep 2001 | - | $205.70M(+0.5%) | $908.08M(+2.9%) |
| Jun 2001 | - | $204.75M(+4.0%) | $882.71M(+1.4%) |
| Mar 2001 | - | $196.96M(-34.5%) | $870.86M(+7.3%) |
| Dec 2000 | $786.86M(+34.9%) | $300.67M(+66.7%) | $811.48M(+10.9%) |
| Sep 2000 | - | $180.33M(-6.5%) | $731.91M(+7.6%) |
| Jun 2000 | - | $192.90M(+40.2%) | $680.02M(+11.9%) |
| Mar 2000 | - | $137.58M(-37.8%) | $607.97M(+4.2%) |
| Dec 1999 | $583.20M(+21.5%) | $221.10M(+72.1%) | $583.20M(+8.5%) |
| Sep 1999 | - | $128.44M(+6.3%) | $537.73M(+2.1%) |
| Jun 1999 | - | $120.84M(+7.1%) | $526.59M(+6.5%) |
| Mar 1999 | - | $112.82M(-35.8%) | $494.45M(+3.1%) |
| Dec 1998 | $479.83M(-1.7%) | $175.63M(+49.7%) | $479.73M(+57.8%) |
| Sep 1998 | - | $117.30M(+32.2%) | $304.10M(+62.8%) |
| Jun 1998 | - | $88.70M(-9.6%) | $186.80M(+90.4%) |
| Mar 1998 | - | $98.10M | $98.10M |
| Dec 1997 | $488.00M(+21.0%) | - | - |
| Dec 1996 | $403.40M(+22.3%) | - | - |
| Dec 1995 | $329.80M(+5.7%) | - | - |
| Dec 1994 | $312.10M(+33.7%) | - | - |
| Dec 1993 | $233.50M(+35.4%) | - | - |
| Dec 1992 | $172.50M(+29.7%) | - | - |
| Dec 1991 | $133.00M(-3.4%) | - | - |
| Dec 1990 | $137.70M(+37.2%) | - | - |
| Dec 1989 | $100.40M(+23.0%) | - | - |
| Dec 1988 | $81.60M(+49.2%) | - | - |
| Mar 1987 | $54.70M(+68.8%) | - | - |
| Mar 1986 | $32.40M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual gross profit?
- What is the all time high annual gross profit for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual gross profit year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly gross profit?
- What is the all time high quarterly gross profit for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly gross profit year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM gross profit?
- What is the all time high TTM gross profit for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM gross profit year-on-year change?
What is Teva Pharmaceutical Industries Limited annual gross profit?
The current annual gross profit of TEVA is $8.06B
What is the all time high annual gross profit for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual gross profit is $11.65B
What is Teva Pharmaceutical Industries Limited annual gross profit year-on-year change?
Over the past year, TEVA annual gross profit has changed by +$419.00M (+5.48%)
What is Teva Pharmaceutical Industries Limited quarterly gross profit?
The current quarterly gross profit of TEVA is $2.12B
What is the all time high quarterly gross profit for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly gross profit is $3.18B
What is Teva Pharmaceutical Industries Limited quarterly gross profit year-on-year change?
Over the past year, TEVA quarterly gross profit has changed by +$350.00M (+19.76%)
What is Teva Pharmaceutical Industries Limited TTM gross profit?
The current TTM gross profit of TEVA is $8.06B
What is the all time high TTM gross profit for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM gross profit is $11.70B
What is Teva Pharmaceutical Industries Limited TTM gross profit year-on-year change?
Over the past year, TEVA TTM gross profit has changed by +$231.00M (+2.95%)